2026 ICD-10-CM Diagnosis Code E32.1Abscess of thymus
ICD-10-CM Codes›E00–E89›E20-E35›E32
- Billable — Valid for Submission
- CC — Complication or Comorbidity
- Not Chronic
E32.1 is a billable ICD-10-CM diagnosis code for abscess of thymus. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 791, 793, 814 through 816. As a secondary diagnosis, it counts as a complication or comorbidity (CC) and moves an inpatient stay to a higher severity level within its MS-DRG family. It does not count, however, when the principal diagnosis is one of 11 closely related codes. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified and unspecified endocrine disorders.
E32.1 no longer risk-adjusts for Medicare Advantage: it mapped to HCC 23 under the retired CMS-HCC V24 model through payment year 2025 but maps to no category in the live V28 model. It still risk-adjusts in the PACE (CMS-HCC V22) category 23, ESRD (V21) category 23, ESRD (V24) category 23, and RxHCC Part D (V08) category 43 for payment year 2026.
Code Identity
Code Classification
Medicare Risk Adjustment (HCC)Billing
E32.1 no longer risk-adjusts for Medicare Advantage: it maps to no payment category in the live CMS-HCC V28 model, although it still risk-adjusts in the other CMS models shown below.
Source: CMS Payment Year 2026 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Abscess of thymus
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
Abscess (connective tissue) (embolic) (fistulous) (infective) (metastatic) (multiple) (pernicious) (pyogenic) (septic) L02.91
thymus (gland) E32.1
Suppuration, suppurative See Also: condition;
thymus (gland) E32.1
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Patient EducationClinical
Abscess
An abscess is a pocket of pus. You can get an abscess almost anywhere in your body. When an area of your body becomes infected, your body's immune system tries to fight the infection. White blood cells go to the infected area, collect within the damaged tissue, and cause inflammation. During this process, pus forms.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert E32.1 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About E32.1Overview
What is the ICD-10 code for abscess of thymus?
The ICD-10-CM code for abscess of thymus is E32.1 (sometimes written as E321). It is billable on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
Is E32.1 (Diseases of thymus) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report abscess of thymus on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does E32.1 group to?
When abscess of thymus is the principal diagnosis on an inpatient stay, it groups to MS-DRG 791, 793, 814, 815, 816, with relative weights from 0.6320 to 4.1696 depending on complications. Higher weights mean higher Medicare reimbursement.
Is E32.1 a CC or MCC?
CMS lists E32.1 as a CC (complication or comorbidity) for FY 2026. Reported as a secondary diagnosis, it moves the inpatient stay to a higher-weighted DRG within its severity family. It does not count when the principal diagnosis is one of the 11 closely related codes in its exclusion list.
What is the ICD-9 equivalent of E32.1?
Under the General Equivalence Mappings, abscess of thymus converts to ICD-9-CM 254.1 (abscess of thymus). The mapping is a direct match.
Does E32.1 risk-adjust for Medicare Advantage payment?
Not for Medicare Advantage. E32.1 mapped to HCC 23 in the retired CMS-HCC V24 model, which last determined payment in 2025, but it maps to no category in the live V28 model; see all codes that no longer risk-adjust. It still risk-adjusts in the PACE (CMS-HCC V22) category 23 (Other Significant Endocrine and Metabolic Disorders), ESRD (V21) category 23 (Other Significant Endocrine and Metabolic Disorders), ESRD (V24) category 23 (Other Significant Endocrine and Metabolic Disorders), and RxHCC Part D (V08) category 43 (Pituitary, Adrenal Gland, and Other Endocrine and Metabolic Disorders).